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Abstract
HIV infection rates have reached epidemic proportions amongst injecting drug users (IDUs) in Iran.
Although a number of community-based interventions have being implemented in the country,
there is little information on the risk behaviors of IDU participants in these programs. This cross-
sectional report aimed to compare the risk behaviors of injecting drug users with differential
exposure rates to an HIV outreach program in Tehran, Iran. Results indicated that shared use of
needle/syringe in the past month was significantly lower among IDUs who received estimated ≥ 7
syringes per week than those who did not [adjusted odds ratio (OR) = 14.36, 95% confidence
interval (CI) 2.30–89.56]. While the effectiveness of this outreach program needs further
evaluation through a longitudinal investigation, our preliminary findings suggest that the outreach
program in Tehran may have been beneficial in reducing direct sharing among those who received
more than several needles/syringes from the program.
Findings
Injecting drug use, to date, has been reported as the main
route of HIV transmission in Iran [1,2] and recent figures
show that the prevalence of HIV infection has reached to
high levels among IDUs in the capital, Tehran [3]. In a
series of attempts to prevent HIV transmission among
IDUs, an outreach program for HIV prevention was sup-
ported by the United Nations Office on Drug and Crimes
(UNODC) and the Ministry of Health of Iran in 2003 [4].
As a part of this outreach program, distribution and
exchange of needles and syringes have been facilitated by
a non-governmental organization (NGO) named Persep-
olis Society in its single (at that time) drop-in centre and
through outreach activities in a neighborhood in Tehran
where many drug users live and street-based drug sales
have been going on. While methadone maintenance ther-
apy and referrals for detoxification were available at/
through the drop-in centre, IDUs who did not want to
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participate in substitute therapy or detoxification were
provided with a package containing 4 syringes/needles, 4
extra needles, water vials, filters, alcohol pads, and 2 con-
doms at each visit. However, IDUs were provided with
large numbers of needles/syringes and condoms if they
requested so. Cookers were also offered, but infrequently.
In October 2004, one year after the establishment of the
outreach program, a convenience sample of drug users
(consisting 213 IDUs and 85 non-IDUs) was recruited at
the drop-in centre, and at parks and streets in the area.
Active drug users were approached by an ex-user staff
member of the NGO for recruitment and were then inter-
viewed by a male researcher not affiliated with the Perse-
polis Society. In the questionnaire-based interview,
participants were asked about their demographics and
HIV risk characteristics, as well as their contact with the
outreach program, estimated length of contact, and the
total number of syringes they received from the program.
Of 131 male injecting drug users who ever received free
needles/syringes from the program, data of the 105 male
IDUs with a complete set of variables for multivariate
analysis were considered for this report and then catego-
rized based on the rate of exposure to the program. The
sub-sample was divided into two groups of IDUs who
received few needle/syringes (< 7 syringes per week) (37/
105 = 35%) and those who received estimated ≥ 7 syringes
per week during their participation in the program (68/
105 = 65%). While adjusted for demographics and basic
drug use characteristics, a logistic regression analysis was
performed to assess the association between having
received ≥ 7 syringes per week from the program and the
related behavioral variables (Table). The research protocol
was approved by the Ethical Committee of the Iranian
National Center for Addiction Studies at Tehran Univer-
sity of Medical Sciences in Iran and by the Committee for
Research on Human Subjects at Kyoto University in Japan.
The median age of IDUs in this sub-sample was 32.0 years
and 67% had educational levels of junior high school or
more. Up to 61% were jobless at the time of interview and
52% have ever been married. Among socio-demographic
characteristics, only being recruited from the drop-in cen-
tre and having lived for 6 years or more in that area were
associated with having received ≥ 7 syringes per week
from the program in the bivariate analysis.
While 18.9% (7/37) of those who received few needles/
syringes from the program reported having injected using
a shared needle or syringe at last injection, none of the 68
IDUs who received ≥ 7 syringes per week from the
program shared a needle/syringe at last injection (P  =
0.000) (not in the Table). Also, shared use of needles/
syringes in the past month was significantly lower among
those IDUs who received ≥ 7 syringes per week than those
who did not (adjusted OR = 14.36, 95% CI, 2.30–89.56;
P  value = 0.004). However, there was no difference
between two groups in the use of a shared cooker at last
injection, condom use during last sex, levels of HIV/AIDS
knowledge, and a history of previous HIV testing (Table).
Effectiveness of needle/syringe programs in reducing nee-
dle and syringe sharing among IDUs has been shown in
Table 1: Association between having received ≥ 7 syringes/week from the outreach program and related behavioral characteristics
Characteristics Total No. 
(%)
Received < 7 
syringes per 
week from the 
program
Received ≥ 7 
syringes per 
week from the 
program
Crude odds ratio 
(95% CI)
P valuea Adjusted odds 
ratio (95% CI)
P value
Overall 105 37 68 - - - -
Did not share needle/syringe 
during last month
90 (85.7) 24 (64.9) 66 (97.1) 17.87 (3.75–85.08) 0.000 14.36 (2.30–89.56) 0.004
Did not share a cooker at 
last injection
37 (35.2) 11 (29.7) 26 (38.2) 1.46 (0.62–3.45) 0.383 0.65 (0.20–2.08) 0.468
Used condom at last sex/
never had sex
40 (38.1) 14 (37.8) 26 (38.2) 1.01 (0.44–2.32) 0.968 0.67 (0.22–2.06) 0.488
Know HIV can be 
transmitted through shared 
needle/syringe
101 (96.2) 36 (97.3) 65 (95.6) 0.60 (0.06–6.00) 1.000b 1.98 (0.14–26.43) 0.605
Ever tested for HIV 63 (60.0) 22 (59.5) 41 (60.3) 1.03 (0.45–2.34) 0.934 0.62 (0.20–1.96) 0.424
Variables shown in this table are controlled for age, ethnicity, marital status, educational levels, recruitment site, length of residency in the area, 
length of lifetime drug injecting, size of drug use network, and frequency of daily drug injecting.
aP values based on chi-square test of proportions unless otherwise specified.
bTwo-tailed Fisher exact test. OR, odds ratio; CI, confidence interval.Harm Reduction Journal 2005, 2:19 http://www.harmreductionjournal.com/content/2/1/19
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many countries [5-9]. Our findings show that those IDUs
who received many syringes from the program reported
less sharing of needles/syringes in the past month than
those who received few syringes. While it is possible that
like many other observations [5], the distribution/
exchange of free needles/syringes resulted in the lower
sharing of needles/syringes among IDUs, a rival hypothe-
sis should also be considered: those IDUs who shared nee-
dles/syringes less frequently in the past month may have
already had higher risk perception and actively sought
and received more syringes from the program. In either
situation, the needle and syringe program in Tehran can
be considered beneficial in that it either resulted in less
sharing of needles and syringes, or at least provided easy
access to clean needles/syringes for IDUs whether or not
any behavior change occurred.
Cooker sharing that has been less targeted in the program
was at high rates among both groups without any signifi-
cant difference. Because of the importance of cooker shar-
ing in the transmission of blood-borne infections [10,11],
the need to address the barriers to distributing cookers has
been identified by this study, and efficient ways to prevent
cooker sharing are being examined.
This study had several limitations. Though the association
between having received many needles/syringes from the
program and low rates of sharing needles/syringes in the
past month is quite strong, because of the cross-sectional
design of this study, it is not possible to draw a conclusion
on the direction of this association. In addition, our com-
parison might have been affected by the selection bias due
to convenience sampling. Though yet to be confirmed in
studies with more robust design, the above preliminary
findings suggest that the HIV outreach program in Tehran
may have been beneficial in reducing needle/syringe shar-
ing but not in reducing cooker sharing among IDU
participants.
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